| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |